Aion Investment Management
VC Fund
Yeoksamdong, South Korea
Aion Investment Management is a VC fund in Yeoksamdong focused on Apps and Web3. Aion Investment Management specializes in financial investment and management consulting services.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Aion Investment Management invests in
Stages Aion Investment Management invests in
Countries Aion Investment Management invests in
Investment Focus
Industry
- Apps 1 (20%)
- Web3 1 (20%)
- EdTech 1 (20%)
- Gaming 1 (20%)
- Medical 1 (20%)
Stage
- Series B 4 (80%)
- Venture - Series Unknown 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Redbrick
|
We employ real-time user code analysis algorithm based on compiler technology to diagnose learners’ levels and status of the software education. And our AI tutor for coding education using deep learning technology offers learner-centered customized learning contents to the users. Aiming for the global market, we are developing and growing ourbusiness to solve the shortage problem of software education instructors and also provide the market with the best quality software education service. | $13.7M / Series B / Jul 20, 2022 | |
brick
|
Redbrick, a tech startup founded in 2018, aims to democratize the creation of games and metaverse content. It offers a cloud-based 3D creation engine, which has significantly lowered the entry barrier to game development that was previously complex and challenging. Redbrick's 3D creation engine leverages Artificial Intelligence GeneratedContent (AIGC), Educational Technology (Edtech), and Blockchain technology, enabling anyone to easily and quickly create games, metaverse, VR, and AR content. Additionally, the Redbrick Store allows for the monetization of these creative works. Currently, Redbrick boasts over 200,000 UGC (User Generated Content) game creators and more than 1 million users. | Series B / Jul 20, 2022 | |
Orum Therapeutics
|
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibodytherapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification. | $54M / Series B / Jun 23, 2021 | |
Team O2
|
Team O2 is an O2O specializes IT company. | $8.9M / Series B / Mar 22, 2021 | |
NovaCell Technology
|
NovaCell Technology produces biomaterials using peptide libraries and proteome profiling technology, it selects potential peptide and biomarker candidates from a set of model systems. It creates biopharmaceuticals and biomaterials based on technologies for proteomics and peptide libraries. | $11.2M / Venture - Series Unknown / Sep 21, 2020 |
Co-Investors
NH Investment & Securities
3 deals together
YG Investment
3 deals together
SK Rent a Car
1 deal together
Atinum Partners
1 deal together
Atinum Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Aion Investment Management invest in?
Aion Investment Management invests primarily in Apps, Web3 and EdTech startups, most often at Series B and Venture - Series Unknown stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Aion Investment Management last invest?
The most recent investment recorded for Aion Investment Management closed in Jul 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
